Merck fourth-quarter earnings rise two per cent; Wyeth swings to a profit

NEW YORK (AP) - Merck & Co. said Tuesday its profit edged up two per cent in the fourth quarter as drug sales levelled off and it set aside an additional $295 million US for legal defence costs related to its withdrawn painkiller Vioxx....More